As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Specialty Generics Market: By Route of Administration: Injectable, Oral, Others; By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Others; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2015-2025); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Specialty Generics Market Outlook

The global specialty generics market size reached a value of almost USD 45.6 billion in the year 2019. The industry is further expected to grow at a CAGR of 12% between 2020 and 2025 to reach a value of almost USD 90 billion by 2025.

The global specialty generics market is driven by the research and development activities, globally. North America is the leading regional market for specialty generics, bolstered by the increasing cases of chronic and complex health conditions such as cancer, epilepsy, HIV, autoimmune diseases, Hepatitis, multiple sclerosis, and rheumatoid arthritis in the region. Specialty generics offer a cost-effective alternative to the branded versions as they do not require costly development and marketing costs, which is further aiding the industry growth.

 

Properties and Applications

Specialty generics are referred to as off-patented drugs, which are used to treat chronic or complex health conditions. These drugs require special handling, monitoring, and usually require prior authorisation to order them. Currently, specialty generics are gaining enormous popularity as they are utilised to treat rare chronic diseases like HIV AIDS, cancer, rheumatoid arthritis, and haemophilia.

The specialty generics market is segmented on the basis of route of administration:

  • Injectable
  • Oral
  • Others

Currently, injectables dominate the market across the globe.

On the basis of indication, the specialty generics market is categorised into:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Among all of these, oncology accounts for the majority of the global market share.

On the basis of distribution channel, the industry is divided into:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies
  • Others

Presently, the products are majorly distributed through the medium of specialty pharmacies.

The report also covers the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Market Analysis

The global specialty generics market is driven by the supporting policies and regulations by the governments of several countries to help in the production of specialty generics. In addition to this, specialty generic drugs are less expensive to produce and manufacture as compared to newly patented drugs, as they are not required to go through any clinical trials and approval prior to entering the industry. On account of this, these products offer low risk and high margins in comparison to newly patented drugs, which generally take about 3- 4 years in product development and approval. 
 
The industry is further aided by the rising research and development (R&D) activities to create new and innovative formulations that offer more efficient and cost-effective options as compared to their branded counterparts. Moreover, many companies are expanding their capacities as they are getting involved with mergers and acquisitions (M&A). For instance, Alvogen, a pharmaceutical company, acquired County Line Pharmaceuticals, a company committed to the formulation of specialty generics.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the global specialty generics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Mallinckrodt plc
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd
  • Apotex Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Specialty Generics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Specialty Generics Historical Market (2015-2019) 
    8.3    Global Specialty Generics Market Forecast (2020-2025)
    8.4    Global Specialty Generics Market by Route of Administration
        8.4.1    Injectable
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2015-2019)
            8.4.1.3    Forecast Trend (2020-2025)
        8.4.2    Oral
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2015-2019)
            8.4.2.3    Forecast Trend (2020-2025)
        8.4.3    Others
    8.5    Global Specialty Generics Market by Indication
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2015-2019)
            8.5.1.3    Forecast Trend (2020-2025)
        8.5.2    Autoimmune Diseases
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2015-2019)
            8.5.2.3    Forecast Trend (2020-2025)
        8.5.3    Infectious Diseases
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2015-2019)
            8.5.3.3    Forecast Trend (2020-2025)
        8.5.4    Others
    8.6    Global Specialty Generics Market by Distribution Channel
        8.6.1    Retail Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2015-2019)
            8.6.1.3    Forecast Trend (2020-2025)
        8.6.2    Specialty Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2015-2019)
            8.6.2.3    Forecast Trend (2020-2025)
        8.6.3    Hospital Pharmacies
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2015-2019)
            8.6.3.3    Forecast Trend (2020-2025)
        8.6.4    Others
    8.7    Global Specialty Generics Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2015-2019)
        9.1.2    Forecast Trend (2020-2025)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2015-2019)
        9.2.2    Forecast Trend (2020-2025)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Market (2015-2019)
        9.3.2    Market Forecast (2020-2025)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2015-2019)
        9.4.2    Forecast Trend (2020-2025)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2015-2019)
        9.5.2    Forecast Trend (2020-2025)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyers Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players’ Market Share
    12.3    Company Profiles
        12.3.1    Teva Pharmaceutical Industries Ltd.
            12.3.1.1    Company Overview
            12.3.1.2    Product Portfolio
            12.3.1.3    Demographic Reach and Achievements
            12.3.1.4    Financial Summary
            12.3.1.5    Certifications
        12.3.2    Mylan N.V.
            12.3.2.1    Company Overview
            12.3.2.2    Product Portfolio
            12.3.2.3    Demographic Reach and Achievements
            12.3.2.4    Financial Summary
            12.3.2.5    Certifications
        12.3.3    Mallinckrodt plc
            12.3.3.1    Company Overview
            12.3.3.2    Product Portfolio
            12.3.3.3    Demographic Reach and Achievements
            12.3.3.4    Financial Summary
            12.3.3.5    Certifications
        12.3.4    Pfizer, Inc.
            12.3.4.1    Company Overview
            12.3.4.2    Product Portfolio
            12.3.4.3    Demographic Reach and Achievements
            12.3.4.4    Financial Summary
            12.3.4.5    Certifications
        12.3.5    Sun Pharmaceutical Industries Ltd
            12.3.5.1    Company Overview
            12.3.5.2    Product Portfolio
            12.3.5.3    Demographic Reach and Achievements
            12.3.5.4    Financial Summary
            12.3.5.5    Certifications
        12.3.6    Apotex Inc.
            12.3.6.1    Company Overview
            12.3.6.2    Product Portfolio
            12.3.6.3    Demographic Reach and Achievements
            12.3.6.4    Financial Summary
            12.3.6.5    Certifications
        12.3.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Specialty Generics Market: Key Industry Highlights, 2015 and 2025
2.    Global Specialty Generics Historical Market: Breakup by Route of Administration (USD Billion), 2015-2019
3.    Global Specialty Generics Market Forecast: Breakup by Route of Administration (USD Billion), 2020-2025
4.    Global Specialty Generics Historical Market: Breakup by Indication (USD Billion), 2015-2019
5.    Global Specialty Generics Market Forecast: Breakup by Indication (USD Billion), 2020-2025
6.    Global Specialty Generics Historical Market: Breakup by Distribution Channel (USD Billion), 2015-2019
7.    Global Specialty Generics Market Forecast: Breakup by Distribution Channel (USD Billion), 2020-2025
8.    Global Specialty Generics Historical Market: Breakup by Region (USD Billion), 2015-2019
9.    Global Specialty Generics Market Forecast: Breakup by Region (USD Billion), 2020-2025
10.    North America Specialty Generics Historical Market: Breakup by Country (USD Billion), 2015-2019
11.    North America Specialty Generics Market Forecast: Breakup by Country (USD Billion), 2020-2025
12.    Europe Specialty Generics Historical Market: Breakup by Country (USD Billion), 2015-2019
13.    Europe Specialty Generics Market Forecast: Breakup by Country (USD Billion), 2020-2025
14.    Asia Pacific Specialty Generics Historical Market: Breakup by Country (USD Billion), 2015-2019
15.    Asia Pacific Specialty Generics Market Forecast: Breakup by Country (USD Billion), 2020-2025
16.    Latin America Specialty Generics Historical Market: Breakup by Country (USD Billion), 2015-2019
17.    Latin America Specialty Generics Market Forecast: Breakup by Country (USD Billion), 2020-2025
18.    Middle East and Africa Specialty Generics Historical Market: Breakup by Country (USD Billion), 2015-2019
19.    Middle East and Africa Specialty Generics Forecast: Breakup by Country (USD Billion), 2020-2025
20.    Global Specialty Generics Market Structure

Key Questions Answered in the Report

The global specialty generics market reached a value of USD 45.6 billion in 2019. 

The market is projected to grow at a CAGR of nearly 12% in the forecast period of 2020-2025.

The market is estimated to reach a value of about USD 90 billion by 2025.

The major drivers of the industry include the rising disposable incomes, increasing population, research and development activities, and the rising competition among key players.

The rising supporting policies and regulations by the governments are expected to be the key trends guiding the growth of the industry.

North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.

Injectables is the dominant route of administration of the product in the market. 

Oncology is the leading indication of the product in the industry. 

The specialty pharmacies segment accounts for the largest market share, among other distribution channels in the industry.

The leading players in the market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Inc., among others.

Analyst Review

The global specialty generics market attained a value of USD 45.6 billion in 2019, driven by the rising research and development activities. Aided by the growing pharmaceuticals sector, the industry is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 12%. The industry is projected to reach USD 90 billion by 2025. 

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its route of administration, the industry can be segmented into injectable and oral, among others, with injectable accounting for the largest market share. By indication, oncology leads the industry. On the basis of distribution channel, the specialty pharmacy segment accounts for the largest share in the global industry. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include Teva Pharmaceutical Industries Ltd., Mylan N.V., Mallinckrodt plc, Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition. 

Purchase Full Report

Mini Report

$1099
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports




Global Generic Drug Market Report and Forecast 2020-2025


NEWSLETTER